Mammalian G1, and G2 Phase Checkpoints

Cancer Surveys

Volumn 29, Issue , 1997, Pages 151-182

  O'Connor, P M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARBOPLATIN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; DNA; DOXORUBICIN; ETOPOSIDE; IRINOTECAN; MELPHALAN; MITOMYCIN C; RETINOBLASTOMA PROTEIN; TOPOTECAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE;

APOPTOSIS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; DNA CROSS LINKING; DNA DAMAGE; DNA STRAND BREAKAGE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; CELL LINE; CHEMISTRY; DNA REPAIR; GENE EXPRESSION REGULATION; GENETICS; MAMMAL; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASES; DNA DAMAGE; DNA REPAIR; G1 PHASE; G2 PHASE; GENE EXPRESSION REGULATION; GENES, P53; MAMMALS; PHOSPHORYLATION; RETINOBLASTOMA;

EID: 0030612166     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (169)

1. Agarwal ML, Argarwal A, Taylor WR and Stark GR (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates growth arrest in human fibroblasts. Proceedings of the National Academy of Sciences of the USA 92 8493-8497
2. Amon A, Surana U, Muroff I and Nasmyth K (1992) Regulation of p34Cdc28 tyrosine phosphorylation is not required for entry into mitosis in S. cerevisiae. Nature 355 368-371
3. Aprelikova O, Xiong Y and Liu ET (1995) Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. Journal of Biological Chemistry 270 18195-18197
4. Bae I, Fan S, Bhatia K, Kohn KW, Fornace AJ Jr and O'Connor PM (1995) Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following γ-irradiation of human lymphoma cells. Cancer Research 55 2387-2393
5. Barlow C, Hirotsune S, Paylor R et al(1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86 159-171
6. Bates PR and Lavin MF (1989) Comparison of gamma-radiation induced accumulation of ataxia telangiectasia and control cells in G2 phase. Mutation Research 218 165-170
7. Bhatia K, Fan S, Spangler G et al(1995) A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma. Cancer Research 55 1431-1435
8. Boise LH, Gonzalez-Garcia M, Postema CE et al(1993) bcl-x, a bcl2 related gene that functions as a dominant regulator of apoptotic death. Cell 74 597-608
9. Brachman DG, Beckett M, Graves D, Haraf D, Vokes E and Weichselbaum RR (1993) p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research 53 3667-3669
10. Brown R, Clugston C, Burns P et al(1993) Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. International Journal of Cancer 55 678-684
11. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377 552-557
12. Caelles G, Helmberg A and Karin M (1994) p53-dependent apoptosis is not mediated by transcriptional activation of p53-target genes. Nature 370 220-223
13. Canman CE, Gilmer TM, Couts SB and Kastan MB (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes and Development 9 600-611
14. Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr, Vogelstein B and Kastan MB (1994) Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proceedings of the National Academy of Sciences of the USA 91 2684-2688
15. Chen IT, Smith ML, O'Connor PM and Fornace AJ Jr (1995) Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA. Oncogene 11 1931-1937
16. Chen IT, Akamatsu M, Smith ML et al(1996) Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 12 595-607
17. Chen J, Jackson PK, Kirschner MW and Dutta A (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374 386-388
18. Chen X, Bargonetti J and Prives C (1995) p53, through p21 (WAF1/GIP1), induces cyclin D1 synthesis. Cancer Research 55 4257-4263
19. Cho Y, Gorina S, Jeffrey PD and Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265 346-356
20. Clarke AR, Purdie CA, Harrison DJ et al(1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362 849-852
21. Deng C, Zhang P, Harper JW, Elledge SJ and Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 675-684
22. Dezube BJ, Eder JP and Pardee AB (1990) Phase I trial of escalating pentoxifylline dose with constant thiotepa. Cancer Research 50 6806-6810
23. Di Leonardo A, Linke SP, Clarkin K and Wahl GM (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes and Development 8 2540-2551
24. Dulic V, Kaufmann WK, Wilson SJ et al(1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76 1013-23
25. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B (1992) Definition of a consensus binding site for p53. Nature Genetics 1 45-49
26. El-Deiry WS, Tokino T, Velculescu VE et al(1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75 817-825
27. El-Deiry WS, Harper JW, O'Connor PM et al(1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Research 54 1169-1174
28. Enoch T and Nurse P (1990) Mutation of fission yeast cell cycle control genes abolishes dependence of mitosis on DNA replication. Cell 60 665-673
29. Fan S, El-Deiry WS, Bae I et al(1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Research 54 5824-5830
30. Fan S, Smith ML, Rivet DJ II et al(1995) Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Research 55 1649-54
31. Fan S, Chang JK, Smith ML, Duba D, Fornace AJ Jr and O'Connor PM Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene (in press)
32. Fingert HJ, Chang JD and Pardee AB (1986) Cytotoxic, cell cycle and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Research 46 2463-2467
33. Flores-Rozas H, Keiman Z, Dean FB et al(1994) Cdk-interacting protein-1 (Cip1, Waf1) directly binds to proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ holoenzyme. Proceedings of the National Academy of Sciences of the USA 91 8655-8659
34. Ford JM and Hanawalt PC (1995) Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proceedings of the National Academy of Sciences of the USA 92 8876-8880
35. Fornace AJ Jr, Alamo I and Hollander MC (1988) DNA damage-inducible transcripts in mammalian cells. Proceedings of the National Academy of Sciences of the USA 85 8800-8804
36. Fotedar R, Fitzgerald P, Rousselle T et al(1996) p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene 12 2155-2164
37. Friend S (1994) p53: a glimpse at the puppet behind the shadow play. Science 265 334-335
38. Funk WD, Pak DT, Karas RH, Wright WE and Shay JW (1992) A transcriptionally active DNA-binding site for human p53 protein complexes. Molecular and Cellular Biology 12 2866-2871
39. Goubin F and Ducommun B (1995) Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10 2281-2287
40. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research 54 4855-4878
41. Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E and Cox LS (1995) Characterization of the interaction between PCNA and Gadd45. Oncogene 10 2427-2433
42. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 805-816
43. Harper JW, Elledge SJ, Keyomarsi K et al(1995) Inhibition of cyclin-dependent kinases by p21. Molecular Biology of the Cell 6 387-400
44. Hartwell L (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71 543-546
45. Hartwell L and Weinert T (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246 629-634
46. Hartwell LH and Kastan MB (1994) Cell cycle control and cancer. Science 266 1821-1828
47. Heald R, McLoughlin M and Mckeon F (1993) Human Weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 74 463-474
48. Helin K, Harlow E and Fattaey A (1993) Inhibition of E2F1 transactivation by direct binding of the retinoblastoma protein. Molecular and Cellular Biology 13 6501-6508
49. Hoffmann I, Clarke PC, Marcote MJ, Karsenti E and Draetta G (1993) Phosphorylation and activation of human Cdc25C by Cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO Journal 12 53-63
50. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253 49-52
51. Hong J-H, Gatti RA, Huo YK, Chiang CS and McBride WH (1994) G2/M phase arrest and release in ataxia telangiectasia and normal cells after exposure to ionizing radiation. Radiation Research 140 17-23
52. Houldsworth J and Lavin MF (1980) Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells. Nucleic Acids Research 8 3709-3720
53. Huang L-C, Clarkin KC and Wahl GM (1996) Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proceedings of the National Academy of Sciences of the USA 93 4827-4832
54. Hupp TR, Sparks A and Lane DP (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83 237-245
55. Jayaraman L and Prives C (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81 1021-1029
56. Kao GD, McKenna WG, Maity A, Blank K and Muschel RJ Cyclin B1 availability is a rate-limiting component of the radiation-induced delay in HeLa cell. Cancer Research (in press)
57. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Research 51 6304-6311
58. Kastan MB, Zhan Q, El-Deiry WS et al(1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71 587-597
59. Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D- dependent kinase CDK4. Genes and Development 7 331-342
60. Kaufmann WK, Levedakou EN, Grady HL, Paules RS and Stein GH (1995) Attenuation of G2 checkpoint function precedes human cell immortilization. Cancer Research 55 7-11
61. Kazantev A and Sancar A (1995) Does p53 up-regulated Gadd45 protein have a role in excision repair? Science 10 1003-1004
62. Kearsey JM, Shivji MK, Hall PA and Wood RD (1995) Does the p53-up-regulated Gadd45 protein have a role in excision repair? Science 10 1004-1005
63. Kern SE, Kinzler KW, Bruskin A et al(1991) Identification of p53 as a sequence-specific DNA- binding protein. Science 252 1708-1711
64. Kessis T, Slebos RJ, Nelson WG et al(1993) Human papillomavirus 16 E6 expression disrupts the p53 mediated cellular response to DNA damage. Proceedings of the National Academy of Sciences of the USA 90 3988-3992
65. Krek W and Nigg EA (1991) Mutations in p34Cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34Cdc2 kinase activation in vertebrates. EMBO Journal 10 3331-3341
66. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proceedings of the National Academy of Sciences of the USA89 7491-7495
67. Kulesz-Martin MF, Lisafeld B, Huang H, Kisiel ND and Lee L (1994) Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells. Molecular and Cellular Biology 14 1698-1708
68. Lane DP (1992) p53, guardian of the genome. Nature 358 15-16
69. Latham KM, Eastman SW, Wong A and Hinds PW (1996) Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases. Molecular and Cellular Biology 16 4445-4455
70. Lau CC and Pardee AB (1982) Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proceedings of the National Academy of Sciences of the USA 79 2942-2946
71. Lee JM and Bernstein A (1993) p53 mutations increase resistance to ionizing radiation. Pro- ceedings of the National Academy of Sciences of the USA 90 5742-5746
72. Lee M-H, Reynisdottir I and Massague J (1995) Cloning of p57Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes and Development 9 539-649
73. Lee S, Elenbaas B, Levine A and Griffith J (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81 1013- 1020
74. Levine A, Momand J and Finlay CA (1991) The p53 tumor suppressor gene. Nature 351 453- 456
75. Lin D, Fiscella M, O'Connor PM et al(1994) Constitutive expression of B-myb can bypass p53- induced Waf1/Cip1-mediated G1 arrest. Proceedings of the National Academy of Sciences of the USA 91 10079-1008
76. Lin J, Reicher X, Wu X and Levine AJ (1996) Analysis of wild-type and mutant p21WAF1 gene activities. Molecular and Cellular Biology 16 1786-1793
77. Livingstone LR, Whitem A, Sprousem J, Livanosm E, Jacks T and Tlsty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70 923- 935
78. Lock RB (1992) Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Research 52 1817-1822
79. Lock RB and Ross WE (1990a) Inhibition of p34Cdc2 kinase induced by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Cancer Research 50 3761-376
80. Lock RB and Ross WE (1990b) Possible role for p34Cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Research 50 3767-3771
81. Lock RB and Keeling PK (1993) Responses of HeLa and Chinese hamster ovary p34Cdc2/cyclin B-kinase in relation to cell cycle perturbations induced by etoposide. International Journal of Oncology 3 33-42
82. Lowe SW, Ruley HE, Jacks T and Houseman DE (1993a) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74 957-967
83. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993b) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 847-849
84. Luo Y, Hurwitz J and Massague J (1995) Cell cycle inhibition by independent Cdk and PCNA binding domains in p21Cip1. Nature 375 159-161
85. Lydall D and Weinert T (1995) Yeast checkpoint genes in DNA damage processing: implications for repair and arrest. Science 270 1488-1491
86. Mac-Donald RE, Wu GS, Waldman T and El-Deiry WS (1996) Repair defect in p21WAF1/CIP1 -/- human cancer cells. Cancer Research 56 2250-2255
87. Mack DH, Vartikar J, Pipas JM and Laimins LA (1993) Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363 281-283
88. McKenna WG, Iliakis G, Weiss MC, Bernhard EJ and Muschel RJ (1991) Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the on- cogenes H-ras and V-myc. Radiation Research 125 283-287
89. Magrath I (1990) The pathogenesis of Burkitt's lymphoma. Advances in Cancer Research 5 133-270
90. Maity A, McKenna WG and Muschel RJ (1995) Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cell. EMBO Journal 14 603-609
91. Maltzman W and Czyzyk L (1984) UV irradiation stimulates levels of p53 cellular antigen in non transformed mouse cells. Molecular and Cellular Biology 4 1689-1694
92. Martinez J, Georgoff I, Martinez J and Levine AJ (1991) Cellular localization and cell cycle regulation by a temperature mutant p53 protein. Genes and Development 5 151-159
93. Matsuoka S, Edwards M, Bai C et al(1995) p57Kip2, a structurally related distinct member of the p21Cip1 Cdk inhibitor family, is a candidate tumor suppressor. Genes and Development 9 650-662
94. Metting NF and Little JB (1995) Transient failure to dephosphorylate the Cdc2-cyclin B1 complex accompanies radiation-induced G2 phase arrest in HeLa cells. Radiation Research 143 286-292
95. Michalovitz D, Halevy O and Oren M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature sensitive mutant p53. Cell 62 671-680
96. Millar JB, Blevitt J, Gerace L, Sadhu K, Featherstone C and Russel P (1991) p55Cdc25C is a nuclear protein required for the initiation of mitosis in human cells. Proceedings of the National Academy of Sciences of the USA 88 10500-10504
97. Miyashita T and Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 293-299
98. Miyashita T, Krajewski S, Krajewski M et al(1994) Tumor suppressor p53 is a regulator of bcl2 and bax gene expression in vitro and in vivo. Oncogene 9 1799-1805
99. Morgan DO (1995) Principles of CDK regulation. Nature 374 131-134
100. Morris GF, Bischoff JR and Mathews MB (1996) Transcriptional activation of the human proliferating cell nuclear antigen promoter by p53. Proceedings of the National Academy of Sciences of the USA 93 895-899
101. Muller H, Lukas J, Schneider A et al(1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proceedings of the National Academy of Sciences of the USA 91 2945-2949
102. Mummenbrauer T, Janus F, Muller B, Wiesmuller L, Deppert W and Grosse F (1996) p53 protein exhibits 3′ -to-5′ exonuclease activity. Cell 85 1089-1099
103. Murray AW (1992) Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359 599-604
104. Muschel RJ, Zhang HB, Iliakis G and McKenna WG (1991) Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Research 51 5113-5117
105. Muschel RJ, Zhang HB and McKenna WG (1993) Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in HeLa cells. Cancer Research 53 1128-1135
106. Nakanishi M, Robetorge RS, Adami GR, Pereira-Smith OM and Smith JR (1995) Identification of the active region of the DNA synthesis inhibitor gene p21(sdi1/cip1/WAF1). EMBO Journal 14 555-563
107. Nelson WG and Kastan MB (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Molecular and Cellular Biology 14 1815-1823
108. Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncogenes. Science 258 424-429
109. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Experimental Cell Research 211 90-98
110. Nurse P (1990) Universal control mechanism regulating onset of M-phase. Nature 344 503-508
111. Oberosler P, Hloch P, Ramsperger U and Stahl H (1993) p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO Journal 12 2389-2396
112. O'Connor PM and Fan S DNA damage checkpoints: implications for cancer therapy. In: Meijer L, Guidet S and Vogel L (eds). Progress in Cell Cycle Research, Plenum Press, New York (in press)
113. O'Connor PM, Ferris DK, White GA et al(1992) Relationships between cdc2 kinase, DNA crosslinking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth and Differentiation 3 43-52
114. O'Connor PM, Ferris DK, Pagano M et al(1993a) G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. Journal of Biological Chemistry 268 8298-8308
115. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I and Kohn KW (1993b) Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Research 53 4776-80
116. O'Connor PM, Ferris DK, Hoffmann I, Jackman J, Draetta G and Kohn KW (1994) Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proceedings of the National Academy of Sciences of the USA 91 9480-9484
117. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358 80-83
118. Oltvai ZN, Millman CL and Korsmeyer SJ (1993) Bcl2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 609-619
119. Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G (1992) Cyclin A is required at two points in the human cell cycle. EMBO Journal 11 961-971
120. Pagano M, Theodoras AM, Tam SW and Draetta GF (1994) Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes and Development 8 1627-1639
121. Painter RB and Young BR (1980) Radiosensitivity in ataxia telangiectasia: a new explanation. Proceedings of the National Academy of Sciences of the USA 77 7315-7317
122. Pan ZQ, Reardon JT, Li L, Flores-Rozas H, Legerski R, Sancar A and Hurwitz J (1995) Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. Journal of Biological Chemistry 270 22008-22016
123. Pietenpol JA, Tokino T, Thiagalingam S, El-Deiry WS, Kinzler KW and Vogelstein B (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proceedings of the National Academy of Sciences of the USA 91 1998-2002
124. Pines J and Hunter T (1989) Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34Gdc2. Cell 58 833-846
125. Polyak K, Lee M-H, Erdjument-Bromage H et al(1994) Cloning of p27Kip1, a cyclindependent kinase inhibitor and potential mediator of extracellular antimitogenic signals Cell 78 59-66
126. Powell SN, DeFrank JS, Connell P et al(1995) Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Research 55 1643- 1648
127. Prelich G, Kostura M, Marshak DR, Mathews MB and Stillman B (1987) Functional identity of proliferating cell nuclear antigen and a DNA polymerase delta auxiliary protein. Nature 326 471-475
128. Qin X-Q, Livingston DM, Kaelin WG Jr and Adams PD (1994) Deregulated transcription factor E2F-1 expression leads to S phase entry and p53-mediated apoptosis. Proceedings of the National Academy of Sciences of the USA 91 10918-10922
129. Russell KJ, Wiens LW, Galloway DA and Groudine M (1995) Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and competent cells. Cancer Research 55 1639-1642
130. Russo AA, Jeffrey PD, Patten A, Massague J and Pavletich NP (1996) Crystal structure of the p27Kip1 cyclin-dependent kinase inhibitor bound to the cyclin A-CDK2 complex. Nature 382 325-331
131. Savitsky K, Bar-Shira A, Gilad S et al(1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 1749-1753
132. Scott D and Zampetti-Bosseler F (1982) Cell cycle dependence of mitotic delay in X-irradiated normal and ataxia-telangiectasia fibroblasts. International Journal of Radiation Biology 42 679-683
133. Seki T, Yamashita K, Nishitani H, Takagi T, Russel P and Nishimoto T (1992) Chromosome condensation caused by loss of RCC1 function requires the cdc25C protein that is located in the cytoplasm. Molecular Biology of the Cell 3 1373-1388
134. Selvakumaran M, Lin HK, Miyashita T et al(1994) Immediate early up-regulation of bax expression by p53 but not TGFβl: a paradigm for distinct apoptotic pathways. Oncogene 9 1791-1798
135. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79 551-555
136. Shivakumar CV, Brown DR, Deb S and Deb SP (1995) Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Molecular and Cellular Biology 15 6785-6793
137. Shivji MK, Kenny MK and Wood RD (1992) Proliferating cell nuclear antigen is required for nucleotide excision repair. Cell 69 367-374
138. Slebos RJC, Lee MH, Plunkett B et al(1994) p53-dependent G1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proceedings of the National Academy of Sciences of the USA 91 5320-5324
139. Slichenmyer WJ, Nelson WG, Slebos RJ and Kastan MB (1993) Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research 53 4164-4168
140. Smith ML, Chen IT, Zhan Q, et al(1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266 1376-1380
141. Smith ML, Chen IT, Zhan Q, O'Connor PM and Fornace AJ Jr (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10 1053-1059
142. Smith ML, Kotny HU, Zhan Q, Sreenath A, O'Connor PM and Fornace AJ Jr (1996) Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to UV-irradiation or cisplatin. Oncogene 13 2255-2263
143. Sorger PK and Murray AW (1992) S-phase feedback control in budding yeast independent of tyrosine phosphorylation of p34Cdc28. Nature 355 365-367
144. Stewart N, Hicks GG, Paraskeas F and Mowat M (1995) Evidence for a second cell cycle block at G2/M by p53. Oncogene 10 109-115
145. Tam S W, Theodoras AM, Shay JW, Draetta GF and Pagano M (1994) Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9 2663-2674
146. Terada Y, Tatsuka M, Jinno S and Okayama H (1995) Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet light. Nature 376 358-362
147. Toyoshima H and Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78 67-74
148. Waga S, Hannon GJ, Beach D and Stillman B (1994) The p21 inhibitor of cyclin-depndent kinases controls DNA replication by interacting with PCNA. Nature 369 574-578
149. Wagner AJ, Kokontis J M and Hay N (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21Waf1/Cip1. Genes and Development 8 2817-2830
150. Waldman T, Kinzler KW and Vogelstein B (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Research 55 5187-5190
151. Walton MI, Whysong D, O'Connor PM, Hockenbery D, Korsmeyer SJ and Kohn KW (1993) Constitutive expression of human Bcl2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Research 53 1853-1861
152. Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA and O'Connor PM (1996) UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. Journal of the National Cancer Institute 88 956-965
153. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR and Harris CC (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proceedings of the National Academy of Sciences of the USA 91 2230-2234
154. Wang XW, Yeh H, Schaeffer L et al( 1995) p53 modulation of TFIIH associated nucleotide excision repair activity. Nature Genetics 10 188-195
155. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81 323-330
156. Weinert TA and Hartwell LH (1988) The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241 317-322
157. Wu X and Levine AJ (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proceedings of the National Academy of Sciences of the USA 91 3602-3606
158. Wu X, Bayle JH, Olson D and Levine AJ (1993) The p53-mdm-2 autoregulatory feedback loop. Genes and Development 7 1126-1132
159. Xiong Y, Zhang H and Beach D (1992) D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71 505-514
160. Ye XS, Fincher RR, Tang A, O'Donnell KO and Osmani SA (1996) Two S phase checkpoint systems, one involving the function of both BIME and Tyr15 phosphorylation of p34Cdc2, inhibit NIMA and prevent premature mitosis. EMBO Journal 15 3599-3610
161. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70 937-948
162. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352 345-347
163. Yuan Z-M, Huang Y, Whang Y et al(1996) Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382 272-274
164. Zakian RV (1995) ATM-related genes: what do they tell us about functions of the human gene? Cell 82 685-687
165. Zambetti GP and Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB Journal 7 855-65
166. Zampetti-Bosseler F and Scott D (1981) Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. International Journal of Radiation Biology 39 547-558
167. Zhan Q, Fan S, Bae I et al(1994) Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9 3743-51
168. Zhan Q, Alamo I, Yu K et al(1996) The apoptosis-associated γ-ray response of BCL-XL depends on normal p53 function. Oncogene 13 2287-2293
169. Zhang H, Hannon GJ and Beach D (1994) p21-containing complexes exist both in active and inactive states. Genes and Development 8 1750-1758